Latest Institutional Purchases of Innate Pharma Sa (IPHA)
This list provides information on the latest institutional transactions involving Innate Pharma Sa (IPHA) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
8.11K+ 2730.98% |
$16.1K - $19.8K
|
8.41K
$12.1K
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Q1 2024 | |||||||
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
14.6KNew |
$34.5K - $42.6K
|
14.6K
$21K
|
|
Q2 2023 | |||||||
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
205New |
$570 - $718
|
205
$295
|
|
Q4 2022 | |||||||
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
13.3KNew |
$25.3K - $49.7K
|
13.3K
$19.2K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.95KNew |
$5.61K - $11K
|
2.95K
$4.25K
|
|
Q3 2022 | |||||||
Nov 14, 2022
Q3 2022
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
16.1KNew |
$32.2K - $51.5K
|
16.1K
$23.2K
|
|
Q2 2022 | |||||||
Aug 12, 2022
Q2 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
1.98KNew |
$3.96K - $7.03K
|
1.98K
$2.85K
|
|
Q1 2022 | |||||||
May 16, 2022
Q1 2022
|
Captrust Financial Advisors
Raleigh, NC |
BUY
|
- |
905New |
$2.44K - $4.34K
|
905
$1.3K
|